SEC CIK 1610382
Race Geoff
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| NERVview stock → | 51,324 | 2023-05-01 |
Position History — NERV
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — NERV
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2025-12-22 | Grant / award (derivative) | 1,500,000 | $0.00 | 1,500,000 |
| 2024-12-05 | Grant / award (derivative) | 95,000 | $0.00 | 95,000 |
| 2023-10-04 | Grant / award (derivative) | 87,050 | $0.00 | 87,050 |
| 2023-05-01 | Open-market sale | 22,082 | $3.85 | 51,324 |
| 2023-04-28 | Grant / award | 46,987 | $0.00 | 73,406 |
| 2022-12-13 | Grant / award (derivative) | 38,000 | $0.00 | 38,000 |
| 2022-02-16 | Grant / award (derivative) | 200,000 | $0.00 | 200,000 |
| 2020-12-16 | Open-market sale | 6,190 | $2.64 | 211,354 |
| 2020-12-14 | Option exercise (derivative) | 12,500 | $0.00 | 0 |
| 2020-12-14 | Option exercise | 12,500 | — | 217,544 |
| 2020-10-13 | Grant / award (derivative) | 140,000 | $0.00 | 140,000 |
| 2020-06-19 | Grant / award (derivative) | 275,568 | $0.00 | 275,568 |
| 2019-12-31 | Grant / award (derivative) | 74,432 | $0.00 | 74,432 |
| 2019-12-17 | Open-market sale | 5,826 | $7.10 | 205,044 |
| 2019-12-14 | Option exercise (derivative) | 12,500 | $0.00 | 12,500 |
| 2019-12-14 | Option exercise | 12,500 | — | 210,870 |
| 2018-12-17 | Open-market sale | 5,999 | $7.46 | 198,370 |
| 2018-12-14 | Option exercise (derivative) | 12,500 | $0.00 | 25,000 |
| 2018-12-14 | Option exercise | 12,500 | — | 204,369 |
| 2018-12-11 | Grant / award (derivative) | 175,000 | $0.00 | 175,000 |
| 2017-12-14 | Option exercise (derivative) | 12,500 | $0.00 | 37,500 |
| 2017-12-14 | Open-market sale | 5,829 | $5.79 | 191,869 |
| 2017-12-14 | Option exercise | 12,500 | — | 197,698 |
| 2017-12-13 | Grant / award (derivative) | 200,000 | $0.00 | 200,000 |
| 2017-02-06 | Open-market sale | 1,692 | $11.00 | 185,198 |
| 2017-02-03 | Open-market sale | 19,758 | $11.02 | 186,890 |
| 2016-12-14 | Grant / award (derivative) | 100,000 | $0.00 | 100,000 |
| 2016-12-14 | Grant / award (derivative) | 50,000 | $0.00 | 50,000 |
| 2015-12-04 | Grant / award (derivative) | 175,000 | $0.00 | 175,000 |
| 2015-04-14 | Grant / award (derivative) | 213,133 | $0.00 | 213,133 |
| 2014-07-01 | Open-market buy | 33,333 | $6.00 | 206,648 |
| 2014-06-30 | — | — | — | 173,315 |
| 2014-06-30 | Grant / award (derivative) | 97,143 | $0.00 | 97,143 |
| 2014-06-30 | Grant / award (derivative) | 249,442 | $0.00 | 346,585 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.